2021
Guillain-Barré Syndrome as a Complication of COVID-19
Zubair AS, Zubair AS, Desai K, Abulaban A, Roy B. Guillain-Barré Syndrome as a Complication of COVID-19. Cureus 2021, 13: e12695. PMID: 33614303, PMCID: PMC7883582, DOI: 10.7759/cureus.12695.Peer-Reviewed Case Reports and Technical NotesGuillain-Barre syndromeCases of GBSInitial COVID-19 infectionCOVID-19Multiple neurological complicationsIntravenous immunoglobulin therapyNerve conduction studiesCerebrospinal fluid analysisGuillain-Barré syndromeCOVID-19 infectionCoronavirus disease 2019Immunoglobulin therapyNeurological complicationsClinical suspicionSymptom onsetGBS casesIll patientsConduction studiesDisease 2019Correct diagnosisFluid analysisLonger durationComplicationsSyndromeInfection
2020
Clinical characteristics of fibroblast growth factor receptor 3 antibody‐related polyneuropathy: a retrospective study
Kovvuru S, Cardenas Y, Huttner A, Nowak R, Roy B. Clinical characteristics of fibroblast growth factor receptor 3 antibody‐related polyneuropathy: a retrospective study. European Journal Of Neurology 2020, 27: 1310-1318. PMID: 32068339, DOI: 10.1111/ene.14180.Peer-Reviewed Original ResearchConceptsChronic inflammatory neuropathiesInflammatory neuropathiesSensory neuropathyFGFR3 antibodiesDistal lower extremity weaknessIntravenous immunoglobulin responseLower extremity paresthesiasCommon presenting symptomLower extremity weaknessRetrospective chart reviewPure sensory neuropathyHistory of cancerDistal sensationMotor findingsPresenting symptomChart reviewClinical characteristicsDemyelinating featuresNerve biopsySymptom onsetUnsteady gaitClinical presentationFoot dropRetrospective studyAutoimmune diseases